Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
A new class of immune-activating molecules awakens anti-tumor immunity by targeting the tumor’s own defenses
A new algorithm may greatly speed up the process of engineering therapeutic antibodies
By analyzing and comparing the antibodies produced in ill, recovering and vaccinated individuals, Weizmann scientists demonstrate different modes...
When a second infection follows on the heels of a first, the two arms of our immune system may clash